RGBOQ — ReGen Biologics Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for ReGen Biologics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2004 December 31st | 2005 December 31st | 2006 December 31st | C2007 December 31st | 2008 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K/A | 10-K/A | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 12.2 | 13.3 | 7.92 | 4.11 | 0.25 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.044 | 0.05 | 0.083 | 0.236 | 0.233 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 12.5 | 14 | 8.57 | 4.99 | 1.86 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.055 | 0.205 | 0.321 | 0.402 | 0.328 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 12.7 | 14.5 | 9.03 | 5.5 | 2.29 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.19 | 2.65 | 1.34 | 0.655 | 12 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 8.35 | 10.1 | 9.18 | 9.05 | 12.2 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 4.37 | 4.46 | -0.144 | -3.54 | -9.91 |
| Total Liabilities & Shareholders' Equity | 12.7 | 14.5 | 9.03 | 5.5 | 2.29 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |